In addition, immunohistological analysis of tumor tissues or ELISA analysis of blood samples from the patients with lung adenocarcinoma indicate that the levels of IGFBP1 positively correlate with the metastatic recurrence, suggesting the therapeutic and prognostic potential of IGFBP1 for metastatic lung cancer. Here, IGFBP1 is linked to lung adenocarcinoma.